ClinicalTrials.Veeva

Menu
S

Southern Neurology | Sydney, Australia

Research site
(Unclaimed)

Site insights

Top conditions

Top treatments

SHR-1707
XEN1101

Curious how this site stacks up to its peers?

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Active trials

3 of 3 total trials

A Randomized Study of XEN1101 Versus Placebo in Focal-Onset Seizures (X-TOLE2)

The X-TOLE2 Phase 3 clinical trial is a randomized, double-blind, placebo-controlled study that will evaluate the clinical efficacy, safety and toler...

Enrolling
Focal Onset Seizures
Drug: XEN1101
Drug: Placebo

This study is researching an experimental combination treatment with pozelimab and cemdisiran, and cemdisiran monotherapy. The study is focused on pa...

Enrolling
Generalized Myasthenia Gravis
Drug: Pozelimab
Drug: Pozelimab + Cemdisiran

To evaluate the safety, tolerability, pharmacokinetics and pharmacodynamics of SHR-1707 in patients with mild cognitive impairment (MCI) due to Alzhe...

Active, not recruiting
Alzheimer's Disease (AD)
Drug: SHR-1707 injection
Drug: Placebo

Trial sponsors

A
Regeneron Pharmaceuticals logo
X

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems